Glaucoma, Open-Angle research hub

Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

This study looks at whether a form of Vitamin B3, Nicotinamide (NAM), can help slow down sight loss in people recently diagnosed with open-angle glaucoma. It aims to see if NAM, when used with standard treatments, can protect vision.